kelig mahe | fisheries research | Research Excellence Award

Posted on by sciencefather

Dr kelig mahe | fisheries research | Research Excellence Award

Dr.kelig mahe, Ifremer, France

Dr. Kélig MAHE is a leading researcher at IFREMER, specializing in marine science, particularly in the fields of sclerochronology and fisheries. Since 2021, he has been the head of the Halieutiques Manche-Mer du Nord Unit, overseeing numerous national and European projects related to fish age estimation and stock management. Dr. MAHE’s expertise spans biological data coordination, fish age determination workshops, and the development of TNPC software. He has co-supervised 11 PhD students and 12 master’s students, contributing significantly to scientific innovation, as demonstrated by his 2010 award for scientific and technological innovation at IFREMER. His contributions extend internationally, with leadership in numerous European research collaborations.

Professinal Profile

  • orcid

    Education 

    Dr. Kélig MAHE’s academic journey is rooted in marine and environmental sciences. He earned his PhD in Marine Biology from Université du Littoral Côte d’Opale (ULCO) in 2019, focusing on fisheries and environmental ecosystems. Prior to this, he completed his Diplôme d’Etudes Approfondies (DEA) in Coastal and Littoral Ecosystem Dynamics from ULCO in 2002. Dr. MAHE’s foundational knowledge in marine resource management was shaped during his engineering studies at the prestigious Ecole Nationale Supérieure d’Agronomie de Rennes (ENSAR), where he graduated with a specialization in Halieutics in 2003. His multidisciplinary education also includes a Maîtrise des Sciences et Techniques in Environmental Sciences from the University of Rouen, completed in 2001, providing him with a well-rounded scientific background in both marine biology and environmental management.

    Experience 

    Dr. MAHE Kélig has an extensive research career at IFREMER, where he has been actively engaged since 2007. His role evolved from a research cadre to leading the Halieutiques Manche-Mer du Nord Unit in 2021. His vast experience includes coordinating national biological data, managing research programs on fish age estimation, and providing expert advice on stock management. His involvement in European research projects is extensive, including leadership positions in projects like Med-Units, Sumaris, and Microtolithe. Dr. MAHE has also represented IFREMER in international workshops and played a pivotal role in advancing sclerochronology, both through research and the development of TNPC software. His management experience includes overseeing teams and mentoring students, making significant contributions to both scientific research and talent development.

    Awards and Honors 

    Dr. MAHE Kélig’s distinguished contributions to marine science have earned him notable recognition. In 2010, he was awarded the IFREMER Trophée de l’innovation for his pioneering work in scientific, technical, and technological fields. His leadership and contributions have made a global impact, notably in European research collaborations, where he co-chaired 13 international workshops and participated in 4 European working groups. His expertise in sclerochronology has positioned him as an expert for IFREMER in international fora. Dr. MAHE’s influence extends to organizing international symposia, such as the 6th International Symposium on Biological Shape Analysis in 2019. His collaborative spirit and innovative work have consistently advanced marine research, particularly in fisheries biology, earning him respect and recognition within the global scientific community.

    Research Focus

    Dr. MAHE Kélig’s research centers on sclerochronology, the study of calcified structures in fish, to improve age determination methods and enhance fisheries management. His work plays a critical role in understanding fish population dynamics and the impacts of environmental changes, such as temperature fluctuations and CO2 levels, on marine species. Dr. MAHE has been at the forefront of integrating modern technologies in fisheries research, particularly through his contributions to the TNPC software for processing calcified structures. His research also extends to interdisciplinary collaborations, where he has led and participated in numerous European projects, focusing on sustainable fishery practices, species population structures, and biogeographical studies. His commitment to research excellence is evidenced by his active role in advancing knowledge in otolith morphogenesis, age determination, and stock management, all of which are pivotal for sustainable marine resource management.

     Publications Top Notes

    1. 🐟 Asymmetry of Sagittal Otolith Shape in Mediterranean Red Mullet: Comparative Analysis of 2D and 3D Otolith Shape Data (2023).
    2. 🌊 Effect of Temperature and CO2 on Morphogenesis of Sagittal Otoliths in Atlantic Herring (2023).
    3. 📊 Spatial Structuring of Demersal Fish Around Réunion Island Based on Otolith Shape (2023).
    4. 🧬 New Scale Analyses Reveal Centenarian African Coelacanths (2021).
    5. 🐠 Complementarity and Discriminatory Power of Genotype and Otolith Shape in Eastern English Channel Sole (2020).

Mohammadreza Alizadeh | Medicine and Dentistry | Best Researcher Award Iran

Posted on by sciencefather

Dr Mohammadreza Alizadeh | Medicine and Dentistry | Best Researcher Award

Dr.Mohammadreza Alizadeh, Iran University of Medical Sciences, Iran

Dr. Mohammadreza (Danial) Alizadeh is a highly skilled medical doctor with expertise in general and aesthetic practice. He graduated from Shahid Beheshti University of Medical Sciences, where he earned his Doctor of Medicine degree in 2020. With a passion for combining medicine and technology, Dr. Alizadeh’s diverse experiences span neurology, radiology, and health management. Currently, he serves as the Supervisor of Occupational Safety and Health at Saman Dej Alborz Co, while practicing as a General Practitioner in Mazandaran, Iran. His contributions to medical research, especially in neuroimaging, neurology, and brain injuries, reflect his commitment to advancing medical knowledge. Dr. Alizadeh is also fluent in Persian, English, and proficient in several other languages, which enhances his ability to collaborate in global settings. A passionate researcher, he has authored numerous publications in high-impact journals, particularly in neuroimaging and trauma.

Professional Profile

  • google scholor

    Experience:

    Dr. Mohammadreza (Danial) Alizadeh has gained a wealth of experience across diverse medical settings. Since May 2023, he has been working as the Supervisor of Occupational Safety and Health at Saman Dej Alborz Co., Tehran, where he oversees safety protocols in a corporate environment. In parallel, he practices as a General and Aesthetic Practitioner in Amol, Mazandaran, focusing on skincare, aesthetic treatments, and general medicine. From March 2019 to February 2021, Dr. Alizadeh held the same role at Derma Hall Clinic, Tehran, performing various cosmetic procedures and consultations. His formative experience includes a two-year internship at Shahid Beheshti University of Medical Sciences, where he rotated through various medical departments, solidifying his expertise in clinical decision-making, patient care, and research. Throughout his career, he has blended patient care with research, focusing on neuroimaging and radiology, with multiple publications in renowned journals.

    Awards and Honors:

    Dr. Mohammadreza (Danial) Alizadeh has been recognized for his academic and professional excellence throughout his career. His notable achievements include an honor for his contribution to neuroimaging research, particularly in traumatic brain injuries, which has gained international recognition. He has received several awards for his scientific publications in peer-reviewed journals, reflecting his deep involvement in advancing medical science. Dr. Alizadeh was also awarded a distinction for his work in healthcare management during his MBA at Shahid Beheshti University of Medical Sciences, highlighting his leadership capabilities in both clinical and managerial roles. His participation in international conferences and workshops has earned him accolades from the medical community, particularly for his innovative research on neuroimaging techniques in radiology. Moreover, his expertise in aesthetic medicine has brought him local recognition, particularly for his minimally invasive cosmetic procedures.

    Research Focus:

    Dr. Mohammadreza (Danial) Alizadeh’s research primarily focuses on neuroimaging and its application in understanding neurological conditions and brain injuries. He is particularly interested in the diagnostic use of MRI and radiomics in the detection and progression of conditions such as glioblastoma and traumatic brain injury. His research also extends to exploring neuroinflammatory responses and imaging abnormalities associated with neurodegenerative diseases. Dr. Alizadeh is actively involved in studying the impact of aducanumab immunotherapy on amyloid-related imaging abnormalities, a groundbreaking area in Alzheimer’s treatment. His work on the role of psychiatric disorders and neuroimaging has opened new avenues for diagnosing and treating mental health conditions using cutting-edge imaging technologies. Additionally, his research on biomarkers in neurotrauma and the use of artificial intelligence in radiological interpretations reflects his forward-thinking approach to medical research.

    Publications Top Notes:

    1. 🧠 “Imaging spectrum of amyloid-related imaging abnormalities associated with aducanumab immunotherapy”
    2. 🧪 “Clinical Decision Rules in Predicting CT Findings in Mild Traumatic Brain Injury”
    3. 🧬 “Radiomics: Differentiating Progression, Recurrence, and Radionecrosis in Gliomas”
    4. 🦠 “ALK-Positive Histiocytosis: A Deceptive Mimic of Meningioma”
    5. 🧠 “Radiomics in Psychiatric Disorders: An Emerging Diagnostic Tool”
    6. 🦠 “MRI Findings in COVID-19 Associated Encephalitis”
    7. 🧠 “Subcortical Signal Alteration of Corticospinal Tracts in ARIA”
    8. 🧠 “Serum Glial Fibrillary Acidic Protein for Intracranial Lesion Detection”
    9. 🩺 “Migraine and Subclinical Atherosclerosis: A Correlation Study”
    10. 🦠 “Effect of Underlying Diseases on COVID-19 Mortality Rate”
    11. 👶 “Choledochal Cyst in Pregnancy: A Case Report”
    12. 🧠 “Double Cystic Duct Case Report”
    13. 🧪 “Effect of Workshop vs. Lecture on Nursing and Midwifery Students”

 

David Monroy | Ocular Cancer | Best Researcher Award

Posted on by sciencefather

David Monroy | Ocular Cancer | Best Researcher Award

  David Monroy, University of Miami, United States

David Monroy is a dedicated researcher with a strong background in neurocritical care and ophthalmology research. A graduate of Florida International University with a Bachelor of Science in Biological Sciences, David has developed significant expertise through his involvement in cutting-edge research projects. He has contributed to impactful studies at the University of Miami’s Neurology and Bascom Palmer Eye Institute, co-authoring numerous publications in esteemed journals. His focus on ocular surface tumors and brain injury has earned him recognition in the medical research community. David is passionate about scientific discovery and its real-world applications, aiming to bridge the gap between research and patient care. He is currently expanding his knowledge in traumatic brain injuries and their long-term outcomes through ongoing projects. His collaborative spirit and dedication to ethical research practices have positioned him as a promising young researcher in the medical field.

Professional Profile

  • orcid

    Education :

    David Monroy earned his Bachelor of Science in Biological Sciences from Florida International University (FIU) in 2020, where he followed a pre-medical track. As a student at FIU, David participated in various research programs, including the SEA-PHAGES program, where he discovered and analyzed novel bacteriophages. His educational journey was marked by an honors-level academic experience, which equipped him with the critical thinking and technical skills necessary for scientific research. Additionally, his time at FIU fostered a deep interest in neurobiology and medical sciences, which laid the groundwork for his subsequent research into neurocritical care and ophthalmology. Throughout his studies, David developed a comprehensive understanding of biological systems, disease mechanisms, and medical treatments, all while maintaining a high standard of academic achievement. His undergraduate experiences have significantly influenced his career trajectory in medical research.

    Experience :

    David Monroy’s research career includes notable roles such as Neurocritical Care Research Associate at the University of Miami, where he currently supports clinical studies in the neurosurgical intensive care unit. His work involves ensuring adherence to ethical protocols, communicating with patient families, and contributing to impactful studies on traumatic brain injury. Previously, David participated in ophthalmology research at the Bascom Palmer Eye Institute, focusing on ocular surface tumors and diagnostic techniques. He has authored multiple manuscripts and presented research findings at conferences, demonstrating his ability to communicate complex data effectively. During his time at Florida International University, he interned in a Parkinson’s disease research lab, where he gained experience in laboratory techniques and the study of neurodegenerative diseases. David’s career reflects a commitment to advancing medical knowledge through both clinical and basic science research, with a focus on improving patient care outcomes.

    Awards and Honors :

    David Monroy’s research and academic excellence have earned him several accolades. His work at the University of Miami’s Department of Neurology has been recognized for its contributions to understanding traumatic brain injuries, leading to multiple poster presentations at the prestigious Neurocritical Care Society conferences. Additionally, his studies on ocular surface tumors at the Bascom Palmer Eye Institute have resulted in peer-reviewed publications and presentations at the Association for Research in Vision and Ophthalmology (ARVO) conference. David’s commitment to advancing scientific knowledge has been rewarded with co-authorship on high-impact medical papers, underscoring his role in groundbreaking discoveries. While at Florida International University, he was part of the honors college, a testament to his academic dedication. His volunteer efforts, particularly with underserved communities, have also been recognized, reflecting his commitment to both research and service.

    Research Focus :

    David Monroy’s research is primarily focused on neurocritical care and ophthalmology, with an emphasis on traumatic brain injury and ocular surface tumors. In neurocritical care, his work has centered on understanding the cognitive and motor dissociation in brain injury patients, as well as examining the causes of traumatic brain injuries across different demographics. His research aims to improve long-term patient outcomes through innovative treatments and monitoring techniques. In ophthalmology, David has explored the infectious etiology of conjunctival tumors and developed diagnostic modalities for ocular surface squamous neoplasia. His research seeks to enhance early detection and improve therapeutic interventions for patients with ocular diseases. By collaborating with multidisciplinary teams, David continues to contribute to research that bridges the gap between laboratory findings and clinical applications, ensuring that his work has a tangible impact on patient care.

    Publication Top notes :

    • 📘 Alvarez OP., Monroy D., Thura S., et al. Infectious Etiology of Conjunctival Tumors. Expert Review of Ophthalmology, 2024.
    • 👁️ Monroy D., Venkateswaran N., Matthews JL., et al. Conjunctival keratoacanthoma: a clinical and histopathological case series. Canadian Journal of Ophthalmology, 2024.
    • 🔬 Monroy D., Serrano A., Galor A., & Karp CL. Medical treatments for ocular surface squamous neoplasia. Eye, 2023.
    • 💀 Monroy D., Garcia J., Zarate SD., et al. Displaced humeral pathological fracture secondary to intraosseous hemangioma. Radiology Case Reports, 2022.